Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

被引:3
作者
Hugosson, J
Lilja, H
Lodding, P
Pihl, CG
机构
[1] Malmo Univ Hosp, Dept Clin Chem, Malmo, Sweden
[2] Sahlgrens Univ Hosp, Dept Urol, S-41345 Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden
关键词
D O I
10.1159/000052582
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:33 / 34
页数:2
相关论文
共 4 条
  • [1] LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT
    AUS, G
    HUGOSSON, J
    NORLEN, L
    [J]. JOURNAL OF UROLOGY, 1995, 154 (02) : 460 - 465
  • [2] LUNDBERG S, 1970, SCAND J UROL NEPHROL, V4, P9397
  • [3] STAMEY TA, 1993, CANCER, V71, P933, DOI 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO
  • [4] 2-L